|
AU7688998A
(en)
*
|
1997-05-20 |
1998-12-11 |
Trustees Of Columbia University In The City Of New York, The |
Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
|
|
US5977091A
(en)
*
|
1998-09-21 |
1999-11-02 |
The Research Foundation Of State University Of New York |
Method of preventing acute lung injury
|
|
US5998390A
(en)
*
|
1998-09-28 |
1999-12-07 |
The Research Foundation Of State University Of New York |
Combination of bisphosphonate and tetracycline
|
|
US6946453B2
(en)
|
1998-11-18 |
2005-09-20 |
Collagenex Pharmaceuticals, Inc. |
4-dedimethylaminotracycline derivatives
|
|
US6506740B1
(en)
*
|
1998-11-18 |
2003-01-14 |
Robert A. Ashley |
4-dedimethylaminotetracycline derivatives
|
|
US6887678B2
(en)
*
|
1998-12-02 |
2005-05-03 |
Cindy L. Bristow |
Method for the quantitative determination of proteinase inhibitors
|
|
CA2372443C
(en)
*
|
1999-04-30 |
2010-07-13 |
Apt Pharmaceuticals, L.L.C. |
Local administration of anti-malarial agents for the treatment of inflammatory diseases
|
|
GB0004531D0
(en)
*
|
2000-02-25 |
2000-04-19 |
Richards Andrew J M |
The treatment of respiratory diseases
|
|
US6627785B1
(en)
*
|
2000-02-29 |
2003-09-30 |
Virginia Commwealth University |
Wound dressings with protease-lowering activity
|
|
US6503892B2
(en)
*
|
2000-04-26 |
2003-01-07 |
New England Medical Center Hospitals Inc. |
Method of using matrix metalloproteinase inhibitors in filtering blebs following glaucoma filtering surgery and in the treatment of ischemic damage to the retina and optic nerve
|
|
US20020132798A1
(en)
*
|
2000-06-16 |
2002-09-19 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
|
US7247704B2
(en)
*
|
2000-12-18 |
2007-07-24 |
Arriva Pharmaceuticals, Inc. |
Multifunctional protease inhibitors and their use in treatment of disease
|
|
AU2002256092C1
(en)
*
|
2001-04-05 |
2009-10-15 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
JP2004532640A
(ja)
*
|
2001-06-05 |
2004-10-28 |
オークランド ユニサーヴィスィズ リミテッド |
肺機能および障害の評価のための方法および組成物
|
|
EP2329826A1
(en)
|
2001-07-13 |
2011-06-08 |
Paratek Pharmaceuticals, Inc. |
Tetracyclines for the treatment of multiple sclerosis
|
|
US20060194773A1
(en)
*
|
2001-07-13 |
2006-08-31 |
Paratek Pharmaceuticals, Inc. |
Tetracyline compounds having target therapeutic activities
|
|
US20030181371A1
(en)
*
|
2001-12-28 |
2003-09-25 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods of using collajolie
|
|
EP2311799A1
(en)
|
2002-01-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
|
JP2005526754A
(ja)
|
2002-03-08 |
2005-09-08 |
パラテック ファーマシューティカルズ インコーポレイテッド |
アミノメチル置換されたテトラサイクリン化合物
|
|
KR101083498B1
(ko)
|
2002-03-21 |
2011-11-16 |
파라테크 파마슈티컬스, 인크. |
치환된 테트라시클린 화합물
|
|
CA2492273C
(en)
|
2002-07-12 |
2013-02-05 |
Paratek Pharmaceuticals, Inc. |
3, 10, and 12a substituted tetracycline compounds
|
|
US20040092491A1
(en)
*
|
2002-11-09 |
2004-05-13 |
The Research Foundation Of State University Of New York |
Method of treating sepsis-induced ARDS
|
|
ES2534827T3
(es)
|
2003-04-07 |
2015-04-29 |
Supernus Pharmaceuticals, Inc. |
Formulaciones de tetraciclinas en dosis única diaria
|
|
CA2526222A1
(en)
*
|
2003-05-16 |
2004-12-02 |
Arriva Pharmaceuticals, Inc. |
Treatment of respiratory disease associated with matrix metalloprotease inhibitors
|
|
JP4738333B2
(ja)
|
2003-07-09 |
2011-08-03 |
パラテック ファーマシューティカルズ インコーポレイテッド |
９−アミノメチルテトラサイクリン化合物のプロドラッグ
|
|
CA2531728A1
(en)
|
2003-07-09 |
2005-02-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
CA2553510C
(en)
*
|
2004-01-15 |
2012-09-25 |
Paratek Pharmaceuticals, Inc. |
Aromatic a-ring derivatives of tetracycline compounds
|
|
EP2269985A3
(en)
|
2004-10-25 |
2011-09-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
AU2005299294B2
(en)
|
2004-10-25 |
2012-06-07 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
|
KR20080011289A
(ko)
*
|
2005-05-10 |
2008-02-01 |
시너젠즈 바이오사이언스 리미티드 |
폐기능 및 폐질환을 평가하기 위한 성분 및 평가 방법
|
|
WO2006123955A2
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
|
|
WO2006123943A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods of analysis of polymorphisms and uses thereof
|
|
JP2009502809A
(ja)
*
|
2005-07-21 |
2009-01-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
１０−置換テトラサイクリンおよびその使用方法
|
|
US8795730B2
(en)
*
|
2006-01-31 |
2014-08-05 |
David John Vachon |
Compositions and methods for promoting the healing of tissue of multicellular organisms
|
|
PL2109602T3
(pl)
*
|
2006-12-21 |
2014-09-30 |
Paratek Pharm Innc |
Pochodne tetracyliny do leczenia zakażeń bakteryjnych, wirusowych i pasożytniczych
|
|
PT2120963T
(pt)
|
2006-12-21 |
2018-12-17 |
Paratek Pharm Innc |
Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele
|
|
JP2010525069A
(ja)
*
|
2007-04-27 |
2010-07-22 |
パラテック ファーマシューティカルズ インコーポレイテッド |
アミノアルキルテトラサイクリン化合物の合成方法および精製方法
|
|
BRPI0823405A2
(pt)
*
|
2007-07-06 |
2012-12-25 |
Paratek Pharmaceuticals, Inc. |
mÉtodos para sintetizar compostos de tetraciclina substituÍda
|
|
TW202216656A
(zh)
|
2008-05-19 |
2022-05-01 |
美商Ｐｒｔｋ Ｓｐｖ２公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
|
PT2323972E
(pt)
|
2008-08-08 |
2013-10-09 |
Tetraphase Pharmaceuticals Inc |
Compostos de tetraciclina substituídos com c7-flúor
|
|
NZ610356A
(en)
|
2008-08-28 |
2015-03-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP2427425B1
(en)
|
2009-05-08 |
2017-03-08 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
IN2012DN02502A
(https=)
|
2009-08-28 |
2015-08-28 |
Tetraphase Pharmaceuticals Inc |
|
|
TWI592390B
(zh)
|
2010-03-31 |
2017-07-21 |
四相製藥公司 |
聚環狀四環素化合物
|
|
BR112015004523B1
(pt)
|
2012-08-31 |
2020-08-04 |
Tetraphase Pharmaceuticals, Inc |
Compostos de tetraciclina, composições farmacêuticas e seus usos
|
|
CN110582486B
(zh)
|
2016-10-19 |
2024-01-12 |
四相制药公司 |
艾若威四环素的结晶形式
|
|
US12570604B2
(en)
|
2018-11-09 |
2026-03-10 |
Tetraphase Pharmaceuticals, Inc. |
Polymorphic forms of a tetracycline compound and uses thereof
|
|
US20250177318A1
(en)
*
|
2022-01-04 |
2025-06-05 |
The Research Foundation For The State University Of New York |
Cmt-3 formulations and methods of using the same
|